149 related articles for article (PubMed ID: 10901337)
1. Prior benzodiazepine exposure and benzodiazepine treatment outcome.
Rickels K; Freeman EW
J Clin Psychiatry; 2000 Jun; 61(6):409-13. PubMed ID: 10901337
[TBL] [Abstract][Full Text] [Related]
2. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
[TBL] [Abstract][Full Text] [Related]
3. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M
JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
[TBL] [Abstract][Full Text] [Related]
4. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
Rickels K; Schweizer E; Case WG; Greenblatt DJ
Arch Gen Psychiatry; 1990 Oct; 47(10):899-907. PubMed ID: 2222129
[TBL] [Abstract][Full Text] [Related]
5. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
Pecknold JC; Swinson RP; Kuch K; Lewis CP
Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
[TBL] [Abstract][Full Text] [Related]
6. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
Klein E; Colin V; Stolk J; Lenox RH
Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
[TBL] [Abstract][Full Text] [Related]
7. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Lydiard RB; Ballenger JC; Rickels K
J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
[TBL] [Abstract][Full Text] [Related]
8. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
Schmidt PJ; Grover GN; Rubinow DR
Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
[TBL] [Abstract][Full Text] [Related]
9. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
Noyes R; Garvey MJ; Cook B; Suelzer M
Am J Psychiatry; 1991 Apr; 148(4):517-23. PubMed ID: 2006699
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
Small GW; Bystritsky A
J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
Frattola L; Garreau M; Piolti R; Bassi S; Albizzati MG; Borghi C; Morselli PL
Br J Psychiatry; 1994 Jul; 165(1):94-100. PubMed ID: 7802852
[TBL] [Abstract][Full Text] [Related]
12. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder.
DeMartinis N; Rynn M; Rickels K; Mandos L
J Clin Psychiatry; 2000 Feb; 61(2):91-4. PubMed ID: 10732655
[TBL] [Abstract][Full Text] [Related]
13. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
Hadley SJ; Mandel FS; Schweizer E
J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
[TBL] [Abstract][Full Text] [Related]
14. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.
Schweizer E; Rickels K; Case WG; Greenblatt DJ
Arch Gen Psychiatry; 1991 May; 48(5):448-52. PubMed ID: 2021297
[TBL] [Abstract][Full Text] [Related]
15. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Rickels K; Schweizer E; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
[TBL] [Abstract][Full Text] [Related]
16. [The withdrawal syndrome in benzodiazepine dependence and its management].
Străulea AO; Chiriţă V
Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):879-84. PubMed ID: 20191849
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of chronic use of alprazolam and lorazepam.
Romach M; Busto U; Somer G; Kaplan HL; Sellers E
Am J Psychiatry; 1995 Aug; 152(8):1161-7. PubMed ID: 7625464
[TBL] [Abstract][Full Text] [Related]
18. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
Klein E
J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
[TBL] [Abstract][Full Text] [Related]
19. Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
Burrows GD; Norman TR; Judd FK; Marriott PF
J Psychiatr Res; 1990; 24 Suppl 2():65-72. PubMed ID: 1980701
[TBL] [Abstract][Full Text] [Related]
20. Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam.
Roy-Byrne PP; Dager SR; Cowley DS; Vitaliano P; Dunner DL
Am J Psychiatry; 1989 Jul; 146(7):860-5. PubMed ID: 2742010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
